NEW YORK: Funders of research in the US, Canada, and UK are advancing a global funding initiative aimed at better understanding the similarities and differences between progressive brain-deteriorating diseases, such as Alzheimer’s and Parkinson’s, with an expanded partnership and increased funding.
Biomarkers Across Neurodegenerative Diseases (BAND) is a joint initiative of the Alzheimer’s Association and The Michael J. Fox Foundation for Parkinson’s Research based within the US. Joining the collaboration are The Weston Brain Institute in Canada and Alzheimer’s Research UK as the program makes available a second round of research grant awards…